Researchers conducted a systematic review and meta-analysis of nine randomized controlled trials assessing exenatide (Byetta, AstraZeneca), liraglutide (Victoza/Saxenda, Novo Nordisk), semaglutide ...

Neither albiglutide nor exenatide therapy resulted in significant ... and head-to-head versus glargine and liraglutide. One study will also evaluate albiglutide versus sitagliptin in patients ...

Data Sources: PubMed was searched (to December 5, 2011) using the terms exenatide, liraglutide, albiglutide, and lixisenatide. The search was limited to studies published in English and conducted ...

The FDA is probably using the exenatide LAR preclinical data to help assess whether the observations for liraglutide are a class effect, and its stance on the issue will be clarified by the ...